Navigation Links
GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

cancer patients improve (respond), stay the same (stable), or worsen (progress) during treatments. Almost half of the enrolled patients remain in the study.

"These results with pazopanib are very encouraging," said lead investigator Dr. Thomas Hutson, Baylor Sammons/Texas Oncology PA, Dallas, Texas. "The high response rates seen so far in this study show clear clinical activity in advanced or metastatic renal cell carcinoma, and a number of ongoing studies also demonstrate therapeutic promise in several other tumor types."

The most frequent adverse events (AEs) were diarrhea, fatigue, hair color change, nausea, and hypertension. Pazopanib had a low incidence of hand-foot syndrome (10%), rash (12%), hemorrhage (9%), and mucositis (5%). Please see safety considerations below.

The incidence of RCC is rising throughout the world (4) with 208,000 new cases diagnosed annually. (5) Although patients with early-stage disease can potentially be cured with surgery, many will either experience a recurrence after surgery or have advanced or metastatic disease at the time of initial presentation. (6)

RCC is generally resistant to standard chemotherapy, (7) and immunotherapeutic regimens using recombinant human interleukin-2 (IL-2) and recombinant human interferon a-2b (IFN-a), either alone or in combination, have been widely used in patients with advanced disease. Although high-dose IL-2 has shown promise with durable complete remissions observed in 7% of patients, toxicity has limited its widespread use. (8) Lower dose cytokine therapies have not shown the same magnitude of response and are also limited by their toxicity. (8) Recently, several anti-angiogenesis drugs, including sunitinib, sorafenib and bevacizumab have demonstrated clinical activity in patients with advanced or metastatic RCC. (8) Although targeted therapies have advanced the treatment of advanced or metastatic RCC, complete and durable responses are not achieved in the majority of
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:4/24/2015)... -- Bayer Corporation hosted its annual "Take Your Child to Work ... headquarters.  This is Bayer,s second "Take Your Child To Work ... campus, and Thursday,s event welcomed 230 children ready to see ... Fortunately, for the kids, this was not just another ... "Science For A Better Life," Bayer made sure that "Take ...
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
(Date:4/24/2015)... Introduction of new ... tools for radiosurgery/SBRT   The "Elements" ... enhancing the workflow for difficult to treat indications ... - comes full circle with the introduction of ... Elements enable on-the-fly generation of consistent treatment plans ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
... BOSTON, Dec. 9 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... sales for the month of October 2009 and $42,898.42 in ... October 2008 and $32,028.52 for November 2008 respectively. , About ... instrument company whose mission is to develop and market breakthrough ...
... , , , GAITHERSBURG, Md, ... in the development and manufacture of lentiviral gene delivery ... Institutes of Health (NIH) small business innovation research (SBIR) ... Generating Hepatitis C Virus-Like Particles using Lentivirus". In ...
Cached Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2
(Date:4/27/2015)... 2015 Final Cut Pro X ... ProTelestrator from Pixel Film Studios. A telestrator is a device ... a moving or still video image. Telestrators are often used ... plays or incoming weather patterns. , After users are done ... the frame slider to control the speed of the animation. ...
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider of ... the addition of an account manager in Houston. In ... growing customer base, Curtis Rice, an experienced sales professional, ... Manager. Curtis has been added to the team to ... Houston area and beyond. , Curtis brings ...
(Date:4/27/2015)... 2015 Launched by a group ... offered consumers a way to connect to top ... Using a patent-pending Pick Your Price matching algorithm, ... Botox®, laser hair removal and dermal fillers on ... gaps in their schedules. This allows clients to ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 A ... 2015 in the U.S. District Court, Northern District ... ( http://www.testosteronelawsuithub.com/ ) have been consolidated for ... court documents, matters addressed included the intention of ... claims involving their products on preemption grounds, with ...
(Date:4/26/2015)... 26, 2015 Indiana Fiber Network, LLC ... that Brotherhood Mutual Insurance Company has selected IFN as ... Network Infrastructure at Brotherhood Mutual Insurance Company states: “IFN’s ... reliability Brotherhood Mutual needed. We were interested ... worked with us to ensure we achieved both. ” ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:ZendyBeauty Is Pleased to Announce the Expansion and Rebranding of the Company as ZendyHealth.com 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3
... ... on Allied Health Personnel in Ophthalmology (JCAHPO), and the Association of Technical Personnel in ... A Clinical Skills and Reference Guide for the Ophthalmic Technician. , ... St. Paul, MN (Vocus) November ...
... Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates ... treatment guidelines for brain metastases patients. These guidelines were ... Annual Meeting in New Orleans, and were developed over ... medical specialties. Members of the panel analyzed 25,000 brain ...
... Nov. 10 Roxane Laboratories, Inc. announced today the ... Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the ... available in bottles of 100 for immediate shipment to ... Tablets are AB rated to ACEON® (perindopril erbumine) tablets. ...
... be questionable, expert says , TUESDAY, Nov. 10 (HealthDay ... reduce the incidence of gallstones and the need for ... new study indicates. , "We,re talking about people who ... Susan S. Jick, director of the Boston Collaborative Drug ...
... rate of nearly 1 in 4 people , TUESDAY, Nov. ... on Medicare who are hospitalized for heart failure are back ... study reveals. , That should not be happening, said Dr. ... medicine at the Mount Sinai School of Medicine in New ...
... tumours in 50% of mice in a new study published today ... drug also stopped lung cancer tumours from growing and becoming resistant ... are now planning to take the drug into clinical trials, to ... form of lung cancer. One in five people with lung ...
Cached Medicine News:Health News:JCAHPO/ATPO Pocket Guide Launches for Eye Care Professionals 2Health News:JCAHPO/ATPO Pocket Guide Launches for Eye Care Professionals 3Health News:Local Neurosurgeon Co-Authors National Treatment Guidelines for Brain Tumor Patients 2Health News:Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets 2Health News:Statins May Stave Off Gallstones 2Health News:Statins May Stave Off Gallstones 3Health News:The Revolving Door of Heart Failure Hospitalization 2Health News:The Revolving Door of Heart Failure Hospitalization 3Health News:Drug shrinks lung cancer tumors in mice 2Health News:Drug shrinks lung cancer tumors in mice 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Fenestrated large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 8.7 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 9.0 mm and length 7.5 mm....
Medicine Products: